Dashboard
Manage Tickers

EBSEmergent BioSolutions Inc.

NYSE emergentbiosolutions.com


$ 3.29 $ 1.37 (70.98 %)    

Thursday, 02-May-2024 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 433.38 $ 1.06 (0.25 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 510.53 $ 0.00 (0 %)
TLT $ 90.10 $ -0.01 (-0.01 %)
GLD $ 213.26 $ -0.16 (-0.07 %)
$ 3.3
$ 3.00
$ 0.00 x 0
$ 0.00 x 0
$ 2.79 - $ 4.76
$ 1.42 - $ 10.88
150,986,665
na
172.26M
$ 1.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 12-11-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-01-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 07-30-2021 06-30-2021 10-Q
13 04-30-2021 03-31-2021 10-Q
14 02-19-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 07-31-2020 06-30-2020 10-Q
17 05-01-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-02-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-22-2019 12-31-2018 10-K
23 11-02-2018 09-30-2018 10-Q
24 08-03-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 02-23-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-04-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-09-2016 09-30-2016 10-Q
32 08-05-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 03-06-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

emergent-biosolutions-reports-blockbuster-q1-results-raises-guidance-whats-going-on-with-the-stock
Emergent BioSolutions Reports Blockbuster ...
05/02/2024 20:55:07

Emergent reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of losses of 83 cents by 171....

nasdaq-gains-over-200-points-dentsply-sirona-shares-fall-after-q1-results
Nasdaq Gains Over 200 Points; Dentsply Sir...
05/02/2024 18:45:31

dow-surges-over-100-points-conocophillips-earnings-miss-views
Dow Surges Over 100 Points; ConocoPhillips...
05/02/2024 16:37:28

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 16:31:17

nasdaq-jumps-over-100-points-kellanova-posts-upbeat-results
Nasdaq Jumps Over 100 Points; Kellanova Po...
05/02/2024 13:52:05

Core News & Articles
Market-Moving News May 2nd
05/02/2024 12:39:37

ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/02/2024 12:06:54

why-aspen-aerogels-shares-are-trading-higher-by-26-here-are-20-stocks-moving-premarket
Why Aspen Aerogels Shares Are Trading High...
05/02/2024 09:43:31

emergent-biosolutions-q1-2024-adj-eps-059-beats-083-estimate-sales-300400m-beat-224500m-estimate
Emergent BioSolutions Q1 2024 Adj EPS $0.5...
05/01/2024 22:20:38

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $(...

emergent-biosolutions-sees-q2-revenue-160m-210m-vs-2445m-est-updates-fy24-revenue-from-900m-1b-to-1b-11b-vs-102b-est
Emergent BioSolutions Sees Q2 Revenue $160...
05/01/2024 21:15:23

2024 FINANCIAL FORECASTThe Company provides the following updated financial forecast for full year 2024 and initial forecast fo...

emergent-biosolutions-says-these-actions-are-expected-to-result-in-annualized-savings-of-80m-when-fully-implemented-the-costs-associated-with-the-restructuring-plan-are-estimated-to-be-18m-21m-and-are-expected-to-be-primarily-incurred-in-the-second-half-of-2024
Emergent BioSolutions Says These Actions A...
05/01/2024 21:06:55

emergent-biosolutions-announces-strategic-operational-changes-to-stabilize-financial-position-will-lead-to-a-reduction-of-300-employees-across-all-areas-of-the-company
Emergent BioSolutions Announces Strategic ...
05/01/2024 21:05:58

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/01/2024 12:06:50

benchmark-reiterates-buy-on-emergent-biosolutions-maintains-5-price-target
Benchmark Reiterates Buy on Emergent BioSo...
04/11/2024 13:05:21

Benchmark analyst Robert Wasserman reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $5 price target.

emergent-biosolutions-receives-nai-status-for-baltimore-bayview-manufacturing-facility
Emergent BioSolutions Receives NAI Status ...
03/25/2024 12:10:10

why-highpeak-energy-shares-are-trading-lower-by-15-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why HighPeak Energy Shares Are Trading Low...
03/07/2024 18:35:19

Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-exp...

benchmark-upgrades-emergent-biosolutions-to-buy-announces-5-price-target
Benchmark Upgrades Emergent BioSolutions t...
03/07/2024 15:39:16

Benchmark analyst Robert Wasserman upgrades Emergent BioSolutions (NYSE:EBS) from Hold to Buy and announces $5 price target.

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/07/2024 13:06:06

why-rush-street-interactive-shares-are-trading-higher-by-around-25-here-are-20-stocks-moving-premarket
Why Rush Street Interactive Shares Are Tra...
03/07/2024 13:05:46

Shares of Rush Street Interactive, Inc. (NYSE: RSI) rose sharply in today’s pre-market trading as the company reported better...

emergent-biosolutions-reports-q4-results-amends-credit-agreement
Emergent BioSolutions Reports Q4 Results, ...
03/06/2024 22:02:06

Emergent BioSolutions reported quarterly losses of 77 cents per share, missing the analyst consensus estimate of losses of 19 c...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION